A new study finds those women may be at lower risk for developing breast cancer down the road.
Hormone replacement therapy use dropped off dramatically after a large, government-run trial revealed an increase in the risk of strokes, breast and ovarian cancers.
But this latest study in the Lancet Oncology found that longer term use of estrogen-only therapy may actually lower a woman's odds of developing breast cancer.
Study authors add the best use of this therapy is in women with a hysterectomy who need relief of certain menopausal symptoms.
